Formulation of Tenofovir-Loaded Functionalized Solid Lipid Nanoparticles Intended for HIV Prevention
Formulation of Tenofovir-Loaded Functionalized Solid Lipid Nanoparticles Intended for HIV Prevention
复制标题
DOI:
10.1002/jps.22529
复制
发表时间:
2011-08-01
影响因子:
3.8
通讯作者:
Youan, Bi-Botti C.
中科院分区:
文献类型:
--
作者:
Alukda, Dima;Sturgis, Timothy;Youan, Bi-Botti C.
The objective of this study is to engineer polylysine-heparin functionalized solid lipid nanoparticles (fSLNs) for the use of a vaginal microbicide delivery template for HIV prevention. The fSLNs are prepared using a modified phase-inversion technique followed by a layer-by-layer deposition method. The Box-Behnken experimental design is used to analyze the influence of three factors (X-1 = bovine serum albumin concentration, X-2 = pH of the aqueous phase, and X-3 = lipid amount) on the particle mean diameter (PMD) measured by dynamic light scattering (DLS). Tenofovir is used as a model anti-HIV microbicide. The SLNs are also characterized for morphology, zeta potential (zeta), percent drug encapsulation efficiency (EE%), and cytotoxicity on a human vaginal epithelial cell line by electron microscopy, DLS, ultraviolet, and fluorescence spectroscopy, respectively. The statistical model predicts particle size (Y) with 90% confidence and the Y values are significantly affected by X-1 and X-2. The produced fSLNs appear noncytotoxic and exhibit a platelet-like shape with respective PMD, EE%, and zeta value of 153 nm, 8.3%, and - 51mV. These fSLNs intended to be administered topically have the potential to enhance cellular uptake of hydrophobic microbicides and outdistance the virus during the HIV/AIDS infection process, possibly leading to more effective prevention of the disease transmission. (C) 2011 Wiley-Liss, Inc. and the American Pharmacists Association J Pharm Sci 100: 3345-3356, 2011